Cargando…
Local Tumor Recurrence and Escape from Suppression of Bone Resorption With Denosumab Treatment in Two Adolescents With Giant Cell Tumors of Bone
Giant cell tumors of bone (GCTB) may be difficult to resect because of size or location. We describe two adolescents who were treated with denosumab and followed for tumoral and biochemical responses. Denosumab was effective in achieving sufficient regression to allow surgical resection and in prese...
Autores principales: | Akel, Umar, Robinson, Marie‐Eve, Werier, Joel, Rampersaud, Raja, Rakhra, Kawan, Johnston, Donna, Konji, Victor N, Ma, Jinhui, Pagé, Marika, Matzinger, Mary Ann, Ward, Leanne M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808219/ https://www.ncbi.nlm.nih.gov/pubmed/31667453 http://dx.doi.org/10.1002/jbm4.10196 |
Ejemplares similares
-
The Bone Phenotype and Pain Response to Pamidronate in Tyrosine Kinase Inhibitor–Treated Chronic Myelogenous Leukemia
por: Lavoie, Declan C T, et al.
Publicado: (2019) -
Bone turnover rate and bone formation/resorption balance during the early stage after switching from a bone resorption inhibitor to denosumab are predictive factors of bone mineral density change
por: Nakatoh, Shinichi
Publicado: (2017) -
Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone
por: Lipplaa, Astrid, et al.
Publicado: (2019) -
Giant-cell tumor of bone: treatment options and role of denosumab
por: Singh, Arun S, et al.
Publicado: (2015) -
'Salvage Treatment' of Aggressive Giant Cell Tumor of Bones with Denosumab
por: Vaishya, Raju, et al.
Publicado: (2015)